OpenVSafe by OpenVAERS
Search V-safe

BWM-32955-97425

2 vaccinations 7 coded responses 20 check-ins 7 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
726 / AR
Registered
2021-01-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-19
    Registered in v-safe
  2. 2021-01-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Restlessness — Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activities
    Free text: Restlessness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-26
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-02-09
    Dose 2 — Pfizer-BioNTech
  9. 2021-02-09
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  12. 2021-02-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Sneezing — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache · Be unable to do your normal daily activities
    Free text: Sneezing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Nausea
    Free text: Dizzy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness, Nausea
    Adult check-in
  15. 2021-02-16
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Redness, Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-02-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-16
    Survey response — day 35, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-23
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  21. 2021-05-11
    Survey response — 3 months, dose 2
    MedDRA: Palpitations — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Worsening heart palpitations (not anxiety related)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-05-11
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-08-10
    Survey response — 6 months, dose 2
    MedDRA: Intermenstrual bleeding — Feeling: Good
    Free text: Spotting between periods
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2022-02-09
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous, Menstruation irregular, Office visit, Palpitations — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Menstrual irregularities, miscarriages, heart palpitations · Healthcare visit (other): In person, ultrasounds
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-02-09
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2022-02-10

Vaccinations

DoseDateManufacturerCo-administered
12021-01-19Pfizer-BioNTech
22021-02-09Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-05-11 Unsuccessful
2022-02-09 Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-23

Systemic reaction (other): Restlessness

Release 4 — days 1–6 daily, dose 2

2021-02-12

Systemic reaction (other): Sneezing

2021-02-14

Systemic reaction (other): Dizzy

Release 5 — day 35, dose 2

2021-03-16

Symptoms: Fatigue

Release 8 — 3 months, dose 2

2021-05-11

Symptoms: Worsening heart palpitations (not anxiety related)

Release 9 — 6 months, dose 2

2021-08-10

Symptoms: Spotting between periods

Release 11 — 12 months, dose 2

2022-02-09

Symptoms: Menstrual irregularities, miscarriages, heart palpitations
Healthcare visit (other): In person, ultrasounds

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDAbortion spontaneous · · ✓
SDFatigue ✓ ✓ ✓
SDIntermenstrual bleeding ✓ · ✓
SDMenstruation irregular · · ✓
SDPalpitations ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRORestlessness ✓ ✓ ✓
SROSneezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release